Specificity of flavin adenine dinucleotide pyrophosphorylase for flavin phosphates and nucleoside triphosphates

Specificity of flavin adenine dinucleotide pyrophosphorylase for flavin phosphates and nucleoside triphosphates

Vol. 14, No. 6, 1964 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Donald B. McCormick Graduate School of Nutrition Cornell University Ithaca...

302KB Sizes 0 Downloads 49 Views

Vol. 14, No. 6, 1964

BIOCHEMICAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Donald B. McCormick Graduate School of Nutrition Cornell University Ithaca, NewYork

Received

December

18,

1963

The biosynthesis

of flavin

adenine dinucleotide

tissues has been observed by several investigators

(FAD) in plant and animal (1).

The overall

mechanism

of FAD biosynthesis was elucidated by Schrecker and Kornberg (2) who partially purified

an enzyme from yeast which catalyzes

the reversible

and inorganic pyrophosphate from riboflavin-5'-phosphate 5'-triphosphate

(ATP).

synthesis of FAD

(EMN) and adenosine-

That a similar meansfor FAD synthesis occurs in

animal tissues was demonstrated by Watarai --et al (3) who found that liver preparations catalyze the incorporation of FMN (P 32) into FAD without loss of specific tic

radioactivity activity

of the phosphate.

for FAD in liver

plasm and is largely

DeLuca and Kaplan (4) showedthe synthe-

is located in the soluble fraction

maskedby FAD-destroying enzymes which can be partially

removed during purification

of the FAD pyrophosphorylase.

Heretofore a study has not been made on the specificity phorylase for both interacting triphosphate.

substrates, flavin

Since several riboflavin

analogues of FMN (5-‘7), of FAD should be sought. nucleoside triphosphates

phosphate and nucleoside

by flavokinase,

the conversion of the latter

able to support

are converted to

to functional

analogues

Moreover the presence of FAD pyrophosphorylase and in the soluble fraction

of the cell,

but lack of bio-

analogues of FAD in which the adenine moiety is replaced by other

purines or pyrimidines,

*

of FAD pyrophos-

analogues are partially

growth in organisms (1) and, via catalysis

synthetic

of the cyto-

would suggest essentially

Supported by Research Grant AM-04585

absolute specificity

for ATP

frcm the U.S. Public Health Service. 493

Vol. 14, No. 6, 1964

BIOCHEMICAL

and should. bear investigation. phosphorylase from rat liver

AND BIOPHYSICAL

The present study demonstrates that FAD pyroexhibits

a relative

phosphate and an apparent absolute specificity

specificity for ATP.

FMN, FAD, and ribo-and aeoxyribofuranoside-5'-triphosphates

of purines an& pyrimidines were the highest purity Isoriboflavin

C-. flavin

available

DohmeLaboratories. and D-Erythroflavin

64dethylriboflavin

alloxazine

were frcm the Merck Sharp ant

(6,7-dimethyl-9-(1'~D-erythrityl)isoalloxazine)

(8).

g-nitroanilines

were prepared

and aldoses by the method of

(6,7-dimethyl-g-(5'-hydroxypentyl)-

2’,3’,4’-Triaeoxyribaflavin

aa

isoalloxazine)

and Parabo-

(6-methyl-9-(1'~D-ribityl)isoalloxaeine)

corresponding substituted

Kuhn -et -* al

from Sigma Chemical

(5,6-dimethyl-9-(1'~D-ribityl)isoalloxazine

(6,7-dimethyl-g-(1'-D-arabityl)isoalloxazine)

from their

for the flavin

and Methods

Materials

Riboflavin,

RESEARCH COMMUNICATIONS

Z!'-deoxyglyceroflatin

(6,7-dimethyl-g-(3'~hydromropyl)iso-

were synthesized via displacement reactions with the appropriate

alcohol and 1,2-&methyl-4,5-dinitrobenzene

as described by Weygana et al.

The monophosphate ester of each of the flatins the terminal bydroxymethyl and Farkas (10).

amino. (9).

was prepared by phosphorylation

group with dichlorophosphoric

of

acid according to Flexsel

The FAD pyrophosphorylase from rat liver

was partially

purified

as described by DeLuca and Kaplan (4). Mixtures flavin

for assessing substrate reactivity

contained 0.5 I&¶ BMNor other

phosphate,1 d4 ATP or other nucleoside triphosphate,

potassium phosphate buffer

(pH 7.5),

and 2.5 mg. of protein

Incubation was carried out in the dark at 37' for 60 min. minated by heating the mixtures in a boiling

extracted

in 3 ml. total

with 0.25 ml. Of liquid

volume.

The reaction was ter-

water bath for 3 min.

were saturated with (14R4)2S04,the mixtures filtered, the filtrates

1 d4 MgC12, 25 mM

The solutions

and the flavin

(warmed) phenol.

compoundsin

50 Lsmbdaaliquo

of the phenol layer were analyzed for FAD or its analogues by the paper chromatographic method of Giri a solvent

system.

the paper strips

(ll),

with @utyl

alcohol:

acetic acid: water (4:1:5)

The chromatograms were examined under an ultraviolet containing FAD compoundswere cut out and eluted 494

light,

as

and

with 3 IIM potass

Vol. 14, No. 6, 1964

phosphate buffer, metrically

BIOCHEMICAL

pH 7.

AND BIOPHYSICAL

FAD ccqounds in the eluates were determined fluoro-

according to the method of Yagi (12).

and appropriate

RESEARCH COMMUNICATIONS

Flav-ins, flavin

phosphates,

standards also were applied to WhatmanNo. 1 paper and the fluor-

escent spots observed under ultraviolet

light

after

developnent of the chromato-

grams in ascending solvents as described by Huennekensand Felton (13). confirmation

of purity

and mobility

of the flavin

Secondary

compoundswas obtained in this

manner (14). Results and Discussion The

5?

values of flatins,

flavin

phosphates, and flavin

adenlne dinucleotides

are shown in Table I.

TARLEI Paper Chrcmatography of Flavin Compounds Compound

RF values in ascending solvents S % s2 0.30 0.30 0.80 0.53 0.12 0.17

Riboflavin t1 -5'-phosphate II adenine dinucleotide Isoriboflavin I, -5'-phosphate 3, adenine dinucleotide 644ethylriboflavin I, -5'~phosphate II adenine dinucleotide

0.35 0.28 0.50

6,7-Mbranoriboflavin~ I, +*-phosphate 11 adenine dinucleotide D-Araboflavin 9, -5'-phosphate II adenine dinucleotide D-Erythroflavin I, -k'-phosphate II adenine dinucleotide 2',3',4'-Trideoxyriboflavin ‘I +*-phosphate 11 adenine dinucleotide 2'Geoxyglyceroflavin 8, -3'~phosphate II adenine dinucleotide

0.05 0.30

0.23

0.11

0.79 0.17

0.40

0.05 0.25

0.80

0.64

0.09

0.19

0.18 0.45

0.44 0.17 0.06

0.70

0.31 0.60

0.32

0.80 0.20

0.33 0.64 0.32

0.56 0.25 0.57

0.04

0.12

0.05 0.38 0.15 0.05 0.65 0.23

0.07

0.57 0.18 0.06

0.19

0.86 0.28 0.95 0.35 0.w

0.31

= 5%aqueous NafIG04; S2 = n-butyl alcohol: acetic acid: * Solvents system: "I; ase); S3 E pheno : n-butyl alcohol: water (16:3:10, lower water (4:1:5, upper p phase). * !Chis flavin and its nucleotides exhibit a diminished fluorescence efficiency.

495

*

BIOCHEMICAL

Vol. 14, No. 6, 1964

Each of the dinucleotides

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

reported is observed as the enzymatic product in the

FAD pyrophosphorylase reaction with ATP and the respective substrates.

flatin

phosphate as

Thus the pyrophosphorylase has somecapacity for catalyzing

densation of the adenylate moiety of ATR with variously

substituted

ing an orthophosphate ester grouping on the side chain at position zine ring.

the con-

flavins

bear-

9 of the alloxr

However, when FM3 was included with other nucleoside triphosphates Ribo-and deoxyribofuranoside-

replacing ATP, no FAD analogues could be detected. 5'-triphosphates

with inosine,

were all inactive.

guanine, cytosine,

uracil,

This apparent absolute specificity

and thymine as the base

of FAD pyrophosphorylase

for AW would explain why no analogues in which adenine is replaced by other purines or pyrimidines

are found biosynthetically

nucleoside triphosphates The quantitative

even though both enzyme and

occur together in the soluble fraction

assays of enzymatically

of the cytoplasm.

synthesized flavin

adenine dinucleo-

tides are shown in Table II.

TABLE II Enzyme-Catalyzed Formation of Flavin Adenine Mnucleotides Flatin

monophosphateadded (500 pM)

Flav-in adenine dinucleotide hl4

Riboflavin-5'-phosphate Isoriboflavin-5'-phosphate 6+4ethylriboflatin+'-phosphate 6,7-Dibrwnoriboflavin-5'-phosphate D-Araboflavin-5'-phosphate D-Erythroflavin-4'-phosphate 2',3',4'-Trideoxyriboflavin-5'-phosphate 2'-Deoxyriboflavin-3'-phosphate

Under the assay conditions

10.3 28.8 7.5 3.2

1.2 1.2

2.2 1.0

employed, isoriboflavin-5'-phosphate

substrate than the natural one, FMN. As demonstrated earlier 5'-phosphate is not formed in the flavokinase normal phosphorylation is an effective

of riboflavin.

suggest that isoriboflavin

is an even better

(5,6),

isoriboflavin.

reaction and does not inhibit

the

Also it has been shown that isoriboflatin

antagonist to riboflavin

to TPNRcytochrome c reductase -in vitro

formed

in -- viva and inhibits (15).

may competitively 496

Taken altogether

the binding of lMN these findings

displace FMN, both as substrate for

Vol. 14, No. 6, 1964

BIOCHEMICAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

FAD pyrophosphorylase and as coenzyme. The observed conversions of the 5'-phosphates of 6-methylribo-,6,7-dibromoribo-, is supported by their logical

activities

and D-araboflavins

known flavokinase-catalyzed

(1).

gation of the biological

phosphorylations

SFmilarly the formation of a flavin

from D-erythroflavin-4'-phosphate

to their

FAD analogues

(5-7) and bio-

adenine dinucleotide

is supported by the recent syntheses and investi-

activities

of this flavin

and its phosphate ester (16).

with @-hydroxyalkyl

side chains has not yet been

The reactivity

of the flavins

investigated

in other systems.

REIXRFJCES 1. 2.

3. 4. 2. 0.

Beinert, H., in P. D, Boyer, H. Lardy, and K. Myrback (Editors), The -- Enzymes, Vol. II, Academic Press, Inc., NewYork, 1960, p. 339. Schrecker, A. W., and Kornberg, A., 2. Biol, Chem., 182, 795 (1950). Watarai, K., Uchida, T., Ishikawa, E., Itaya,Tand Katsunm, N., Vitamins

(KYoto),

g, 331 (1955).

% 6 (1958). DeLuca, C., and Kaplan, N. O., Biochem. Biophys. Acta, -McCormick, D. B., 2. Biol. Chem., 237, 91591). McCormick, D. B., andxler, R., Bi;;chem. Biophys. Acta, 6& 326 (1962). Mccomick, D. B., Arsenis, C., and-Hamnerich, P., J. B&l. Chem.> .?38, 30% (1963 -z 1jE (1937). Kuhn, R., Vetter, H., and Rzeppa, H., Ber. &.-c&mxs., chs. BtZT, 84T iol (1951). Weygand, F., Lowenfeld, R., and Mollerx, Flexser, L. A., and Farkas, W. G., U. S. Patent 2xO;lF; Chem; Abstr.,s 12379 (1961). Giri, K. V., and Krishnaswamy, P. R., 2. Indian Inst. S&.., 38, 232 (1956). Yagi, K., 2. Biochem. (Tokyo), & 161 (1s Huennekens, F. M., and Felton, S. P., in S. P. Colowick and N. 0. Kaplan (Editors Methods in m Vol. III, Academic Press, Inc., NewYork, 1957, p. 957. Kirmnich,?. A., and McCormick, D. B., J. Chromate;+., in press (1963). Kearney, E. B., 2. Biol. Chem., 194, 767X1952). Uehara, K., Sugeno,r andizoguchi, T., J,. Biochem. (Tokyo), 5& 267 (1963).

87: 9.

10. 11. 12.

13. 14.

15. 16.

497